Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice

Virology

Volumn 400, Issue 2, 2010, Pages 248-258

  Kastrukoff, Lorne F ^a   Lau, Allen S ^a   Takei, Fumio ^b   Smyth, Mark J ^c   Jones, Claerwen M ^d   Clarke, Sally R M ^d   Carbone, Francis R ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

HSV 1; Mucosa; Natural killer (NK) cells; Natural killer T (NKT) cells; T cells; Virus

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GANGLIOSIDE GM1 ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; HERPES SIMPLEX VIRUS 1; KNOCKOUT MOUSE; MOUSE; MOUTH MUCOSA; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

ANIMALS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

HUMAN HERPESVIRUS 1; MUS;

EID: 77949569252     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.02.013     Document Type: Article

References (102)

1. + T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1200-1204.
2. Arduino P.G., Porter S.R. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J. Oral Pathol. Med. 2008, 37:107-121.
3. Baringer J.R., Pisani P. Herpes simplex virus (HSV) nucleic acid in the central nervous system of man. Ann. Neurol. 1994, 26:283-287.
4. Behrens G., Li M., Smith C.M., Belz G.T., Mintern J., Carbone F.R., Heath W.R. Helper T cells, dendritic cells, and CTL immunity. Immunol. Cell Biol. 2004, 82:84-90.
5. Bloom D.C. HSV-1 latency and the roles of the LATs. Molecular and Cellular Biology 2006, 343-360. Caister Academic Press, Norfolk, UK. 1st ed. R.M. Sandri-Goldin (Ed.).
6. Bonneau R.H., Jennings S.R. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adaptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 1989, 63:1480-1484.
7. Borysiewicz L.K., Sissons J.G.P. Cytotoxic T cells and human herpes viral infections. Curr. Top. Microbiol. Immunol. 1994, 189:123-150.
8. Brandt C.R., Salkowski C.A. Activation of NK cells following corneal infection with herpes simplex virus type 1. Invest. Ophthalmol. Vis. Sci. 1992, 33:113-120.
9. Bukowski J.F., Welsh R.M. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J. Immunol. 1986, 136:3481-3485.
10. Cantin E., Tanamachi B., Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 1999, 73:3418-3423.
11. Cantin E., Tanamachi B., Openshaw H., Mann J., Clarke K. Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice. J. Virol. 1999, 73:196-5200.
12. Carr D.J., Tomanek L. Herpes simplex virus and the chemokines that mediate the inflammation. Curr. Top. Microbiol. Immunol. 2006, 303:47-65.
13. Chen Y.H., Chiu N.M., Mandal M., Wang N., Wang C.R. Impaired NK+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997, 6:459-467.
14. Chmielarczyk W., Engler H., Brucher J., Kirchner H. Herpes simplex virus-induced interferon production and activation of NK cells in SM/J mice. Relation to antiviral resistance. Antiviral Res. 1983, 3:325-333.
15. Coles R.M., Mueller S.N., Heath W.R., Carbone F.R., Brooks A.G. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 2002, 168:834-838.
16. Cornish A.L., Keating R., Kyparissoudis K., Smyth M.J., Carbone F., Godfrey D.I. NKT cells are not critical for HSV-1 disease resolution. Immunol. Cell Biol. 2006, 84:13-19.
17. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Kaneko Y., Koseki H., Kanno M., Tanigushi M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997, 278:1623-1626.
18. Fung-Leung W.-P., Schilham M.W., Rahemtulla A., Kundig T.M., Vollenwelder M., Potter J., van Ewijk W., Mak T.W. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 1991, 65:443-449.
19. + T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Microbiol. Pathol. 1999, 27:387-394.
20. Gilden D.H., Gesser R., Smith J., Welsh M., Laguardia J.J., Cohrs R.J., Mahalingam R. Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia. Virus Genes 2001, 23:145-147.
21. Grubor-Bauk B., Simmons A., Mayrhofer G., Speck P.G. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J. Immunol. 2003, 170:1430-1434.
22. Habu S., Akamatsu K., Tamaoki N., Okumura K. In vivo significance of NK cells on resistance against virus (HSV 1) infections in mice. J. Immunol. 1984, 133:2743-2747.
23. Howes E.L., Taylor W., Mitchison N.A., Simpson E. MHC matching shows that at least two T-cell subsets determine resistance to HSV. Nature 1979, 277:66-68.
24. Iijima N., Linehan M.M., Zamora M., Butkus D., Dunn R., Kehry M.R., Laufer T.M., Iwasaki A. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J. Exp. Med. 2008, 205:3041-3052.
25. Itohara S., Mombaerts P., Lafaille J., Iacomini J., Nelson A., Clarke A.R., Hooper M.L., Farr A., Tonegawa S. T cell receptor δ gene mutant mice: independent generation of αβ T cells and programmed rearrangements of γδ TCR genes. Cell 1993, 72:337-348.
26. Itzakhi R.F., Lin W.R., Shang D., Wilcock G.K., Faragher B., Jamieson G.A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997, 349:241-244.
27. Jennings S.R., Bonneau R.M., Smith P.M., Wolcott R.M., Chervenak R. CD4-Positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell. Immunol. 1991, 133:234-252.
28. Johnson R.M., Lancki D.W., Sperling A.I., Dick R.F., Spear P.G., Fitch F.W., Bluestone J.A. A murine CD4-, CD9- T cell receptor-γδ T lymphocyte clone specific for herpes simplex virus glycoprotein 1. J. Immunol. 1992, 148:983-988.
29. Kassim S.H., Rajasagi N.K., Ritz B.W., Pruett S.B., Gardner E.M., Chervenak R., Jennings S.R. Dendritic cells are required for optimal activation of natural killer functions following primary infection with herpes simplex virus type 1 (HSV-1). J. Virol. 2009, 83:3175-3186.
30. Kastrukoff L.F., Long C., Doherty P., Wroblewska Z., Koprowski H. Isolation of virus from brain following immunosuppression of mice with latent herpes simplex virus. Nature 1981, 291:432-433.
31. Kastrukoff L.F., Hamada T., Schumacher U., Long C., Doherty P., Koprowski H. Central nervous system infection, latency, and immune responses in herpes simplex virus type 1 infections in mice. J. Neuroimmunol. 1982, 2:295-305.
32. Kastrukoff L.F., Lau A.S., Puterman M.L. Genetics of natural resistance to herpes simplex virus 1 (HSV 1) latent infection of the peripheral nervous system in mice. J. Gen. Virol. 1986, 67:613-621.
33. Kastrukoff L.F., Lau A.S., Kim S.U. Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1. Ann. Neurol. 1987, 22:52-59.
34. Kastrukoff L.F., Lau A.S., Leung G.Y., Walker D.G., Thomas E.E. Herpes simplex virus type 1 (HSV 1) induced multifocal central nervous system (CNS) demyelination in mice. J. Neuropathol. Exp. Neurol. 1992, 51:432-439.
35. Kastrukoff L.F., Lau A.S., Leung G.Y., Thomas E.E. Contrasting effects of immunosuppression on herpes simplex virus type 1 (HSV 1) induced central nervous system (CNS) demyelination in mice. J. Neurol. Sci. 1993, 117:148-158.
36. Kastrukoff L.F., Jones C.M., Reading P., Smyth M.J., Carbone F.R. The induction of natural killer (NK) cells in C57BL/6 mice following mucosal infection with herpes simplex virus (HSV 1). Clin. Invest. Med. 2004, 27:144B.
37. Kennedy P.G. Viral encephalitis. J. Neurol. 2005, 252:268-272.
38. Khanna K.M., Kepisto A.J., Decman V., Hendricks R.L. Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 2004, 16:463-469.
39. + T cells. Science 1990, 248:1227-1230.
40. Koo G.C., Peppard J.R. Establishment of monoclonal anti-NK1.1 antibody. Hybridoma 1984, 3:301-303.
41. Koo G.C., Peppard J.R., Lattime E.C. Characterization of cytotoxic cells generated from bone marrow culture. Cell. Immunol. 1986, 98:172-180.
42. + T cells into the nervous system following ocular herpes simplex virus-1 infection. J. Immunol. 2005, 174:2919-2925.
43. Larsen H.S., Russell R.G., Rouse B.T. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infect. Immun. 1983, 41:197-204.
44. Larsen H.S., Feng M., Horohov D.W., Moore R.N., Rouse B.T. Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J. Virol. 1984, 50:56-59.
45. Liu T., Tang Q., Hendricks R.L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 1996, 70:264-271.
46. + T-cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 2000, 191:1459-1466.
47. Lopez C. Genetics of natural resistance to herpesvirus infections in mice. Nature 1975, 258:152-153.
48. 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in mice. Infect. Immun. 1980, 28:1028-1032.
49. Lopez C., Kirkpatrick D., Read S., Fitzgerald P.A., Pitt J., Dawha S., Ching C.Y., Smithwick E.M. Correlation between low natural killers of HSV-1 infected fibroblasts, NK (HSV-1) and susceptibility to herpesvirus infections. J. Infect. Dis. 1983, 147:1030-1035.
50. Lundberg P., Welander P., Openshaw H., Nalbandian C., Edwards C., Moldawer L., Cantin E. A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. J. Virol. 2003, 77:11661-11673.
51. Lundberg P., Welander P.V., Edwards C.K., van Rooijen N., Cantin E. Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2. J. Virol. 2007, 81:1451-1460.
52. Lundberg P., Ramakrishna C., Brown J., Tyszka J.M., Hamamura M., Hinton D.R., Kovats S., Nalcioglu O., Weinberg K., Openshaw H., Cantin E.M. The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J. Virol. 2008, 82:7078-7088.
53. Madsen L., Labrecque N., Engberg J., Dierich A., Svejgaard A., Benoist C., Mathis D., Fugger L. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10338-10343.
54. Manicken E., Rouse B. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell deficient mouse models. J. Virol. 1995, 69:8178-8179.
55. + T-cells. J. Virol. 1995, 69:4711-4716.
56. + T lymphocytes. J. Immunol. 1995, 155:259-265.
57. Mendiratta S.K., Martin W.D., Hong S., Boesteanu A., Joyce S., Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997, 6:469-477.
58. + T-cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation. Viral Immunol. 1991, 4:177-186.
59. Mintern J.D., Davey G.M., Belz G.T., Carbone F.R., Heath W.R. Cutting edge: precursor frequency affects the helper dependence of cytotoxic T cells. J. Immunol. 2002, 168:977-980.
60. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-dificient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877.
61. Mossman K. Activation and inhibition of virus and interferon: the herpesvirus story. Viral Immunol. 2002, 15:3-15.
62. Muhlen K.A., Schumann J., Wittke F., Stenger S., van Rooigen N., van Kaer L., Tiegs G. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J. Immunol. 2004, 172:3034-3041.
63. Nandakumar S., Woolard S.N., Yuan D., Rouse B.T., Kumaraguru U. Natural killer cells as novel helpers in anti-HSV immune response. J. Virol. 2008, 82:10820-10831.
64. Nash A.A., Cambouropoulos P. The immune response to herpes simplex virus. Semin. Virol. 1993, 4:181-186.
65. Nash A.A., Phelan J., Wildy P. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J. Immunol. 1981, 126:1260-1262.
66. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 1987, 68:825-833.
67. Newell C.K., Sendele D., Rouse B.T. Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis. Reg. Immunol. 1989, 2:366-369.
68. Pack C.D., Rouse B.T. Immunity to herpes simplex virus: present but not perfect. Molecular and Cellular Biology 2006, 343-360. Caister Academic Press, Norfolk, UK. 1st ed. R.M. Sandri-Goldin (Ed.).
69. Pereira R.A., Scalzo A., Simmons A. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J. Immunol. 2001, 166:5869-5873.
70. Postol E., Meyer A., Cardillo F., de Alencar R., Pessina D., Nihei J., Mariano M., Mengel J. Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent Baff/BLyS production. Immunology 2008, 125:184-196.
71. Rager-Zisman B., Quan P.C., Roser M., Moller J.R., Bloom B.R. Role of NK cells in protection of mice against herpes simplex virus 1 infection. J. Immunol. 1987, 138:874-883.
72. Raulet D.H. MHC Class I-deficient mice. Adv. Immunol. 1994, 55:381-421.
73. Raulet D.H., Vance R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 2006, 6:520-531.
74. Reading P.C., Whitney P.G., Barr D.P., Smyth M.J., Brooks A.G. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur. J. Immunol. 2006, 36:897-905.
75. Rock D.L., Fraser N.W. Detection of HSV-1 genes in the CNS of latently infected mice. Nature 1983, 302:523-525.
76. Roizman B., Knipe D.M. Herpes simplex viruses and their replication. Fields Virology 2001, 2399-2459. Lippincott, Philadelphia, Pa. 4th ed. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
77. Roos K.L. Encephalitis. Neurol. Clin. 1999, 17:813-833.
78. Rossol-Voth R., Rossol S., Schutt K.H., Corridori S., deCian W., Falke D. In vivo protective effect of tumour necrosis factor α against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 1991, 72:143-147.
79. Sciammas R., Johnson R.M., Sperling A.I., Brady W., Linsley P.S., Spear P.G., Fitch F.W., Bluestone J.A. Unique antigen recognition by a herpesvirus-specific TCRγδ cell. J. Immunol. 1994, 152:5392-5397.
80. Sciammas R., Kodukula P., Tang Q., Hendricks R.L., Bluestone J.A. T cell receptor-γδ cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 1997, 185:1969-1975.
81. Simmons A. H-2 linked genes influence the severity of herpes simplex virus infection of the peripheral nervous system. J. Exp. Med. 1989, 169:1503-1507.
82. Simmons A., Nash A.A. Zosteriform spread of herpes simplex virus as a model for recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 1984, 52:816-821.
83. Simmons A., LaVista A.B. Neural infection in mice after cutaneous inoculation with HSV 1 is under complex host genetic control. Virus Res. 1989, 13:263-270.
84. Simmons A., Tscharke D.C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 1992, 175:1337-1344.
85. Smiley S.T., Kaplan M.H., Grusby M.J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997, 275:977-979.
86. Smith P.M., Wolcott R.M., Chervenak R., Jennings S.R. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology 1994, 202:76-88.
87. + T-cell immunity. Nat. Immunol. 2004, 5:1143-1148.
88. Smyth M.J., Crowe N.Y., Godfrey D.I. NK and NKT cells collaborate in host protection from MCA-induced fibrosarcoma. Int. Immunol. 2001, 13:459-465.
89. Stevens J.G., Cook M.L. Latent herpes simplex virus in spinal ganglia of mice. Science 1971, 173:843-845.
90. Trapani J.A., Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2002, 2:735-747.
91. Treiner E., Duban L., Bahram S., Radosavljevic M., Wanner V., Tilloy F., Affaticati P., Gilfillan S., Lantz O. Selection of evolutionarily conserved mucosal-associated invariant T-cells by MR1. Nature 2003, 422:164-169.
92. + T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 2004, 172:392-397.
93. van Lint A.L., Kleinert L., Clarke S.R., Stock A., Heath W.R., Carbone F.R. Latent infection with herpes simplex virus is associated with ongoing CD8+ T-cell stimulation by parenchymal cells within sensory ganglia. J. Virol. 2005, 79:14843-14851.
94. + T cells. J. Immunol. 1993, 150:2346-2355.
95. Vollstedt S., Arnold S., Schwerdel C., Franchini M., Alber G., Di Santo J.P., Ackermann M., Suter M. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 2004, 78:3846-3850.
96. Yokoyama W.M., Kim S. How do natural killer cells find self to achieve tolerance?. Immunity 2006, 24:249-257.
97. Wang M., Ellison C.A., Gartner J.G., HayGlass K.T. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. J. Immunol. 1998, 160:1098-1105.
98. Whitley R.J. Herpes simplex viruses. Fields Virology 2001, 2461-2509. Lippincott, Philadelphia, Pa. 4th ed. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
99. Whitley R.J., Kimberlin D.W., Roizman B. Herpes simplex viruses. Clin. Infect. Dis. 1998, 26:541-555.
100. Wolfer D.P., Crusio W.E., Lipp H.P. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci. 2002, 25:336-340.
101. Wuest T.R., Carr D.J.J. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J. Immunol. 2008, 181:7985-7993.
102. + cytolytic T cells. Nature 1990, 344:742-746.